Published in Healthcare Mergers, Acquisitions and Ventures Week, June 11th, 2005
The newly issued shares were priced at $3.98, the closing price of the company's common stock on April 25, 2005. As part of the offering, investors also received warrants to purchase approximately 2.4 million shares of common stock, exercisable within 5 years at a price of $4.78 per share.
Following the completion of the offering, Advancis was advised by The Nasdaq Stock Market that the offering was completed at a price determined by Nasdaq...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week